Chitosan/Polycyclodextrin (CHT/PCD)-Based Sponges Delivering VEGF to Enhance Angiogenesis for Bone Regeneration.

VEGF-delivery bone tissue engineering cell migration cell proliferation chitosan cyclodextrin polymer sponges

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
19 Aug 2020
Historique:
received: 28 07 2020
revised: 11 08 2020
accepted: 15 08 2020
entrez: 23 8 2020
pubmed: 23 8 2020
medline: 23 8 2020
Statut: epublish

Résumé

Vascularization is one of the main challenges in bone tissue engineering (BTE). In this study, vascular endothelial growth factor (VEGF), known for its angiogenic effect, was delivered by our developed sponge, derived from a polyelectrolyte complexes hydrogel between chitosan (CHT) and

Identifiants

DOI: 10.3390/pharmaceutics12090784 PMID: 32825081 PMC: PMC7557476
pubmed: 32825081
pii: pharmaceutics12090784
doi: 10.3390/pharmaceutics12090784
pmc: PMC7557476
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : FONDECYT-CONCYTEC
ID : 274-2015-FONDECYT

Références

Int J Pharm. 2020 Sep 25;587:119677
pubmed: 32717280
Bioact Mater. 2017 Jun 07;2(4):224-247
pubmed: 29744432
Int J Biol Macromol. 2013 Mar;54:24-9
pubmed: 23201776
Adv Colloid Interface Sci. 2017 Sep;247:589-609
pubmed: 28754381
Carbohydr Polym. 2017 Oct 1;173:535-546
pubmed: 28732897
Bioact Mater. 2018 May 26;3(4):401-417
pubmed: 30003179
Biomaterials. 2010 Jan;31(2):226-41
pubmed: 19800684
Acta Biomater. 2012 Jan;8(1):404-14
pubmed: 21884833
Cell Prolif. 2017 Jun;50(3):
pubmed: 28205330
Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):3780-5
pubmed: 23910277
Arch Biochem Biophys. 2018 Dec 15;660:72-86
pubmed: 30336134
Int J Biol Macromol. 2018 Nov;119:1228-1239
pubmed: 30107161
Dent Mater. 2019 Jul;35(7):1031-1041
pubmed: 31076156
Adv Drug Deliv Rev. 2010 Jan 31;62(1):83-99
pubmed: 19799949
Int J Pharm. 2016 Sep 25;511(2):913-20
pubmed: 27473278
Colloids Surf B Biointerfaces. 2015 Mar 1;127:105-13
pubmed: 25660093
Exp Biol Med (Maywood). 2014 Nov;239(11):1476-88
pubmed: 24872440
Int J Biol Macromol. 2019 Jul 15;133:817-830
pubmed: 31002908
Bone. 2016 Oct;91:30-8
pubmed: 27353702
Nat Rev Drug Discov. 2004 Dec;3(12):1023-35
pubmed: 15573101
Tissue Eng Part A. 2012 May;18(9-10):1079-86
pubmed: 22195699
Carbohydr Polym. 2019 Jan 15;204:59-67
pubmed: 30366543
Crit Rev Biomed Eng. 2012;40(5):363-408
pubmed: 23339648
Adv Drug Deliv Rev. 2012 Sep;64(12):1257-76
pubmed: 22626978
J Clin Invest. 2004 Feb;113(4):516-27
pubmed: 14966561
Carbohydr Polym. 2012 Nov 6;90(4):1695-703
pubmed: 22944435
J Mater Sci Mater Med. 2007 Sep;18(9):1665-74
pubmed: 17483879
Polymers (Basel). 2019 Jan 26;11(2):
pubmed: 30960198
Bone. 2016 Feb;83:197-209
pubmed: 26608518
Int J Pharm. 2019 May 1;562:151-161
pubmed: 30853482
Nat Protoc. 2007;2(2):329-33
pubmed: 17406593
Biomolecules. 2019 Sep 04;9(9):
pubmed: 31487971
Trends Biotechnol. 2018 Aug;36(8):834-849
pubmed: 29555346
Int J Pharm. 2019 Feb 10;556:301-310
pubmed: 30553954
Biomater Sci. 2018 May 29;6(6):1604-1615
pubmed: 29736522
Trends Biotechnol. 2012 Oct;30(10):546-54
pubmed: 22939815
Mater Sci Eng C Mater Biol Appl. 2017 Nov 1;80:532-542
pubmed: 28866197
Genes Dis. 2016 Mar;3(1):56-71
pubmed: 27239485
Adv Healthc Mater. 2017 Mar;6(5):
pubmed: 28135051
Eur J Pharm Biopharm. 2009 Sep;73(1):50-8
pubmed: 19442724
Br J Oral Maxillofac Surg. 2017 Nov;55(9):875-891
pubmed: 29056355
Bioact Mater. 2017 Dec 01;3(3):278-314
pubmed: 29744467
Front Endocrinol (Lausanne). 2013 Aug 26;4:106
pubmed: 23986744
Mater Sci Eng C Mater Biol Appl. 2014 Feb 1;35:401-10
pubmed: 24411394
Gels. 2017 Oct 09;3(4):
pubmed: 30920532
Curr Opin Biotechnol. 2003 Oct;14(5):559-65
pubmed: 14580589
Int J Biol Macromol. 2019 Feb 15;123:622-628
pubmed: 30447364
J Biomed Mater Res A. 2006 Feb;76(2):335-46
pubmed: 16270345
Biomaterials. 2010 Aug;31(24):6279-308
pubmed: 20493521
Adv Drug Deliv Rev. 2010 Jan 31;62(1):3-11
pubmed: 19800377
Sci Rep. 2016 Sep 12;6:32884
pubmed: 27616161
HSS J. 2010 Feb;6(1):85-94
pubmed: 19763695
J Biomed Mater Res A. 2011 Oct;99(1):16-28
pubmed: 21793193
J Control Release. 2015 Jan 10;197:148-57
pubmed: 25445698

Auteurs

Carla Palomino-Durand (C)

U1008 Controlled Drug Delivery Systems and Biomaterials, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire de Lille (CHU Lille), University of Lille, 59000 Lille, France.
ORCID: 0000-0001-7378-0050

Marco Lopez (M)

U1008 Controlled Drug Delivery Systems and Biomaterials, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire de Lille (CHU Lille), University of Lille, 59000 Lille, France.

Pierre Marchandise (P)

ULR 4490-MABLab-Adiposité Médullaire et Os, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire de Lille (CHU Lille), University of Lille, 59000 Lille, France.
ULR 4490-MABLab-Adiposité Médullaire et Os, Univ. Littoral Côte d'Opale, 62200 Boulogne-sur-Mer, France.

Bernard Martel (B)

UMR 8207, UMET-Unité Matériaux et Transformations, Centre National de la Recherche Scientifique (CNRS), Institut National de la Recherche Agronomique (INRA), Ecole Nationale Supérieure de Chimie de Lille (ENSCL), University of Lille, 59655 Lille, France.

Nicolas Blanchemain (N)

U1008 Controlled Drug Delivery Systems and Biomaterials, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire de Lille (CHU Lille), University of Lille, 59000 Lille, France.

Feng Chai (F)

U1008 Controlled Drug Delivery Systems and Biomaterials, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire de Lille (CHU Lille), University of Lille, 59000 Lille, France.

Classifications MeSH